Loading company…
Riskpilot
← Back to search
Sign in
Get full access
TideDisc Biotech ApS
APS
Dissolved
CVR 41819340
Vardegade 2, 3. tv
Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100
Est. 2020
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2022
DKK 55K
-194% vs 2021
EBITDA margin
100.0%
+194% vs 2021
Equity ratio
11.6%
Financial strength
Net profit 2022
DKK 46K
+168% vs 2021
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
Key figures
Annual report 2022
Revenue
DKK 55K
-194%
EBITDA
DKK 55K
+194%
Net profit
DKK 46K
+168%
Total assets
DKK 156K
+76%
Equity
DKK 18K
+166%
Employees
—
—
Company information
Legal name
TideDisc Biotech ApS
CVR number
41819340
Legal form
Anpartsselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
3. november 2020
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem, eller af 2 bestyrelsesmedlemmer.
Contact
Address
Vardegade 2, 3. tv
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Forskning og eksperimentel udvikling indenfor bioteknologi
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
Income statement
DKK thousands
Item
2021
2022
Revenue
-59
55
Staff expenses
-0
-0
EBITDA
-59
55
Depreciation & amort.
-5
-5
EBIT
-64
50
Net financials
-4
-5
Profit before tax
-67
46
Tax
-0
-0
Net profit
-67
46
Balance sheet
DKK thousands
Item
2021
2022
Total assets
89
156
Equity
-27
18
Long-term debt
106
93
Short-term debt
10
45
Total debt
116
138
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2021
2022
Equity ratio
11.6%
This company
38.2%
Market median
-70% vs market
2021
2022
Return on equity
250.9%
This company
18.4%
Market median
+1264% vs market
2021
2022
Net profit margin
82.9%
This company
8.1%
Market median
+923% vs market
2021
2022
Asset turnover
0.35×
This company
1.12×
Market median
-69% vs market
2021
2022
Debt / equity
7.60×
This company
0.62×
Market median
-1126% vs market
2021
2022
Annual reports & filings
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-11-03 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
FG
Frederik Grønbæk Tidemand
Management
Management
2020 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Former (1)
NT
Nicolai Tidemand Johansen
Chairman
2020 – 2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Lise Arleth
Individual
20–24.99%
20–24.99%
2020
Grønbæk Tidemand Holding ApS
Company
33.33–49.99%
33.33–49.99%
2020
Nicotide Holding ApS
Company
33.33–49.99%
33.33–49.99%
2020
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of TideDisc Biotech ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Frederik Grønbæk Tidemand
Management
0 companies
Nicolai Tidemand Johansen
Chairman
0 companies